Cassava Sciences Inc $ 13.69 0.82 (6.37%)
Volume:
397,809
Avg Vol (1m):
2,359,758
Market Cap $:
476.77 Mil
Enterprise Value $:
453.01 Mil
P/E (TTM):
0.00
P/B:
14.21
Current and historical daily P/E ratio for SAVA (Cassava Sciences Inc) from 2000 to Jan 25 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Cassava Sciences stock (SAVA) PE ratio as of Jan 25 2021 is 0.
More Details
Cassava Sciences PE Ratio (TTM) Chart
EMBED
Cassava Sciences PE Ratio (TTM) Historical Data
View and export this data going back to 2000. Start your Free Trial
Total 1256
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Cassava Sciences PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2021-01-25 | 0.0 | 2020-11-23 | 0.0 |
| 2021-01-22 | 0.0 | 2020-11-20 | 0.0 |
| 2021-01-21 | 0.0 | 2020-11-19 | 0.0 |
| 2021-01-20 | 0.0 | 2020-11-18 | 0.0 |
| 2021-01-19 | 0.0 | 2020-11-17 | 0.0 |
| 2021-01-18 | 0.0 | 2020-11-16 | 0.0 |
| 2021-01-15 | 0.0 | 2020-11-13 | 0.0 |
| 2021-01-14 | 0.0 | 2020-11-12 | 0.0 |
| 2021-01-13 | 0.0 | 2020-11-11 | 0.0 |
| 2021-01-12 | 0.0 | 2020-11-10 | 0.0 |
| 2021-01-11 | 0.0 | 2020-11-09 | 0.0 |
| 2021-01-08 | 0.0 | 2020-11-06 | 0.0 |
| 2021-01-07 | 0.0 | 2020-11-05 | 0.0 |
| 2021-01-06 | 0.0 | 2020-11-04 | 0.0 |
| 2021-01-05 | 0.0 | 2020-11-03 | 0.0 |
| 2021-01-04 | 0.0 | 2020-11-02 | 0.0 |
| 2021-01-01 | 0.0 | 2020-10-30 | 0.0 |
| 2020-12-31 | 0.0 | 2020-10-29 | 0.0 |
| 2020-12-30 | 0.0 | 2020-10-28 | 0.0 |
| 2020-12-29 | 0.0 | 2020-10-27 | 0.0 |
| 2020-12-28 | 0.0 | 2020-10-26 | 0.0 |
| 2020-12-25 | 0.0 | 2020-10-23 | 0.0 |
| 2020-12-24 | 0.0 | 2020-10-22 | 0.0 |
| 2020-12-23 | 0.0 | 2020-10-21 | 0.0 |
| 2020-12-22 | 0.0 | 2020-10-20 | 0.0 |
| 2020-12-21 | 0.0 | 2020-10-19 | 0.0 |
| 2020-12-18 | 0.0 | 2020-10-16 | 0.0 |
| 2020-12-17 | 0.0 | 2020-10-15 | 0.0 |
| 2020-12-16 | 0.0 | 2020-10-14 | 0.0 |
| 2020-12-15 | 0.0 | 2020-10-13 | 0.0 |
| 2020-12-14 | 0.0 | 2020-10-12 | 0.0 |
| 2020-12-11 | 0.0 | 2020-10-09 | 0.0 |
| 2020-12-10 | 0.0 | 2020-10-08 | 0.0 |
| 2020-12-09 | 0.0 | 2020-10-07 | 0.0 |
| 2020-12-08 | 0.0 | 2020-10-06 | 0.0 |
| 2020-12-07 | 0.0 | 2020-10-05 | 0.0 |
| 2020-12-04 | 0.0 | 2020-10-02 | 0.0 |
| 2020-12-03 | 0.0 | 2020-10-01 | 0.0 |
| 2020-12-02 | 0.0 | 2020-09-30 | 0.0 |
| 2020-12-01 | 0.0 | 2020-09-29 | 0.0 |
| 2020-11-30 | 0.0 | 2020-09-28 | 0.0 |
| 2020-11-27 | 0.0 | 2020-09-25 | 0.0 |
| 2020-11-26 | 0.0 | 2020-09-24 | 0.0 |
| 2020-11-25 | 0.0 | 2020-09-23 | 0.0 |
| 2020-11-24 | 0.0 | 2020-09-22 | 0.0 |
Cassava Sciences PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Compare
AMEX:NAVB
NAS:ACRS
NAS:ONCS
NAS:EQ
NAS:CLDX
NAS:NMTR
NAS:MDWD
OTCPK:IPIX
NAS:COCP
NAS:INFI
OCSE:NOVO B
ASX:CSL
NAS:VRTX
NAS:REGN
XKRX:207940
NAS:SGEN
NAS:MRNA
NAS:ALXN
XKRX:068270
NAS:INCY
Address
7801 N. Capital of Texas Highway, Suite 260, Austin, TX, USA, 78731
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. It is also developing an experimental biomarker diagnostic PTI-125 to detect Alzheimer's disease with the help of a blood test.